PUBLICATION
Streptomyces sp. BV410 isolate from chamomile rhizosphere soil efficiently produces staurosporine with antifungal and antiangiogenic properties
- Authors
- Mojicevic, M., D'Agostino, P.M., Pavic, A., Vojnovic, S., Senthamaraikannan, R., Vasiljevic, B., Gulder, T.A.M., Nikodinovic-Runic, J.
- ID
- ZDB-PUB-200129-15
- Date
- 2020
- Source
- MicrobiologyOpen 9(3): e986 (Journal)
- Registered Authors
- Keywords
- Streptomyces sp., antiangiogenesis, antifungal activity, secondary metabolite, staurosporine, zebrafish
- MeSH Terms
-
- Secondary Metabolism
- Chamomile/microbiology*
- Streptomyces/classification
- Streptomyces/genetics
- Streptomyces/isolation & purification*
- Streptomyces/metabolism*
- Zebrafish
- Antifungal Agents/pharmacology*
- Angiogenesis Inhibitors/pharmacology*
- Rhizosphere*
- Staurosporine/biosynthesis*
- Staurosporine/pharmacology*
- Phylogeny
- RNA, Ribosomal, 16S
- Animals
- PubMed
- 31989798 Full text @ Microbiologyopen
Citation
Mojicevic, M., D'Agostino, P.M., Pavic, A., Vojnovic, S., Senthamaraikannan, R., Vasiljevic, B., Gulder, T.A.M., Nikodinovic-Runic, J. (2020) Streptomyces sp. BV410 isolate from chamomile rhizosphere soil efficiently produces staurosporine with antifungal and antiangiogenic properties. MicrobiologyOpen. 9(3):e986.
Abstract
Applying a bioactivity-guided isolation approach, staurosporine was separated and identified as the active principle in the culture extract of the new isolate Streptomyces sp. BV410 collected from the chamomile rhizosphere. The biotechnological production of staurosporine by strain BV410 was optimized to yield 56 mg/L after 14 days of incubation in soy flour-glucose-starch-mannitol-based fermentation medium (JS). The addition of FeSO4 significantly improved the staurosporine yield by 30%, while the addition of ZnSO4 significantly reduced staurosporine yield by 62% in comparison with the starting conditions. Although staurosporine was first isolated in 1977 from Lentzea albida (now Streptomyces staurosporeus) and its potent kinase inhibitory effect has been established, here, the biological activity of this natural product was assessed in depth in vivo using a selection of transgenic zebrafish (Danio rerio) models, including Tg(fli1:EGFP) with green fluorescent protein-labeled endothelial cells allowing visualization and monitoring of blood vessels. This confirmed a remarkable antiangiogenic activity of the compound at doses of 1 ng/ml (2.14 nmol/L) which is below doses inducing toxic effects (45 ng/ml; 75 nmol/L). A new, efficient producing strain of commercially significant staurosporine has been described along with optimized fermentation conditions, which may lead to optimization of the staurosporine scaffold and its wider applicability.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping